Insights

Cost Savings Nurocor’s automation solution claims to save eight million dollars and reduce trial timelines by eight months per Phase 3 trial, signaling a strong value case for CROs, sponsors, and trial operators seeking cost efficiency and faster go-to-market.

Clinical Platform Expansion Recent news indicates upcoming integration with Bristol Myers Squibb to productize and embed Nurocor’s generative AI capabilities into its Clinical Platform, highlighting a potential channel through large pharma partnerships and enterprise-wide deployments.

Strategic Investment A new $1 million investment from Simulations Plus strengthens financial backing and credibility, creating a credibility lever for sales conversations with risk-averse pharmaceutical customers seeking proven vendor relationships.

Digital Protocol Advantage The launch of a digital authoring application and emphasis on connecting digital protocol components with conventional contributions positions Nurocor as a modern, compliant solution provider—appealing to organizations prioritizing regulatory efficiency.

Industry Recognition Awards and conference activity, including a Bio IT World Best of Show win and participation in CDISC US Interchange, bolster market credibility and can be leveraged to accelerate introductions to decision-makers in life sciences IT and clinical operations.

Similar companies to Nurocor, Inc

Nurocor, Inc Tech Stack

Nurocor, Inc uses 8 technology products and services including Amazon Web Services, Kubernetes, GitLab CI, and more. Explore Nurocor, Inc's tech stack below.

Media & News

Nurocor, Inc's Email Address Formats

Nurocor, Inc uses at least 2 email formats:
Nurocor, Inc Email FormatsExamplePercentage
First.Last@nurocor.comJohn.Doe@nurocor.com
99%
FirLast@nurocor.comJohDoe@nurocor.com
1%

Frequently Asked Questions

What is Nurocor, Inc's phone number?

Minus sign iconPlus sign icon
You can contact Nurocor, Inc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nurocor, Inc's official website and social media links?

Minus sign iconPlus sign icon
Nurocor, Inc's official website is nurocor.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Nurocor, Inc generate?

Minus sign iconPlus sign icon
As of August 2026, Nurocor, Inc's annual revenue is estimated to be $25M - $50M.

What is Nurocor, Inc's NAICS code?

Minus sign iconPlus sign icon
Nurocor, Inc's NAICS code is 5112 - Software Publishers.

How many employees does Nurocor, Inc have currently?

Minus sign iconPlus sign icon
As of August 2026, Nurocor, Inc has approximately 48 employees across 2 continents, including North America and Europe. Key team members include Vp Product Management: B. B., Svp, Process And Technology Optimization: M. P. and Director Consulting Services: D. R. Explore Nurocor, Inc's employee directory with LeadIQ.

What industry does Nurocor, Inc belong to?

Minus sign iconPlus sign icon
Nurocor, Inc operates in the Software Development industry.

What technology does Nurocor, Inc use?

Minus sign iconPlus sign icon
Nurocor, Inc's tech stack includes Amazon Web Services, Kubernetes, GitLab CI, Jenkins, Shopify, Atlassian Jira, Elasticsearch and Microsoft Teams.

What is Nurocor, Inc's email format?

Minus sign iconPlus sign icon
Nurocor, Inc's email format typically follows the pattern of First.Last@nurocor.com. Find more Nurocor, Inc email formats with LeadIQ.

How much funding has Nurocor, Inc raised to date?

Minus sign iconPlus sign icon
As of August 2026, Nurocor, Inc has raised $6.3M in funding. The last funding round occurred on Aug 14, 2025 for $1M.
Nurocor, Inc logo

Nurocor, Inc

Software DevelopmentTexas, United States11-50 Employees

Nurocor, Inc is a software development company based in Austin, Texas, focusing on solutions for clinical operations within the pharmaceutical sector. Its offerings aim to reduce trial execution costs and timelines by automating core processes, enabling staff to focus on critical tasks and driving productivity across Trial Execution Teams. The firm targets clinical operations executives and pharmaceutical companies looking to improve quality by design and efficiency in Phase 3 trials, positioning its product as a way to maximize value from existing systems through built-in connectivity. The company has a footprint in the life sciences technology space and has pursued industry engagement through events and recognition, including participation in CDISC Interchanges and awards such as Bio IT World Best of Show. Recent activity includes public disclosures of a new investment and continued development of its cloud-based platform for clinical data management and protocol execution. }

Section iconCompany Overview

Phone number
NAICS Code
5112 - Software Publishers
Employees
11-50

Section iconFunding & Financials

  • $6.3M

    Nurocor, Inc has raised a total of $6.3M of funding over 3 rounds. Their latest funding round was raised on Aug 14, 2025 in the amount of $1M as a Venture Round.

  • $25M - $50M

    Nurocor, Inc's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.